InsidersTradesSigma
Browse the complete record of transactions filed by Daniel Rankin, Membre du Conseil. Director active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 1 reports have been published. The latest transaction was filed on 28 October 2025 — Sale. Regulator: FIN-FSA. The full history is free.
1 of 1 declaration
Daniel Rankin is a Board Member at Swedish Orphan Biovitrum AB (publ). He contributes to the governance of the company by participating in strategic decisions and overseeing operations. His role is crucial for the development of Swedish Orphan Biovitrum AB, a company specializing in biopharmaceutical products.